Compound Global Advisors LLC Sells 2,950 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Compound Global Advisors LLC cut its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 79.7% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 753 shares of the company's stock after selling 2,950 shares during the period. Compound Global Advisors LLC's holdings in HCA Healthcare were worth $260,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the business. Sanders Capital LLC lifted its stake in HCA Healthcare by 1.0% during the fourth quarter. Sanders Capital LLC now owns 11,655,563 shares of the company's stock valued at $3,498,417,000 after purchasing an additional 116,826 shares during the last quarter. First Eagle Investment Management LLC raised its holdings in shares of HCA Healthcare by 0.5% during the fourth quarter. First Eagle Investment Management LLC now owns 4,503,849 shares of the company's stock valued at $1,351,830,000 after acquiring an additional 23,177 shares during the period. Geode Capital Management LLC raised its holdings in shares of HCA Healthcare by 1.3% during the fourth quarter. Geode Capital Management LLC now owns 3,871,057 shares of the company's stock valued at $1,159,882,000 after acquiring an additional 50,321 shares during the period. Capital World Investors raised its holdings in shares of HCA Healthcare by 0.7% during the fourth quarter. Capital World Investors now owns 2,928,452 shares of the company's stock valued at $878,975,000 after acquiring an additional 19,121 shares during the period. Finally, Norges Bank acquired a new stake in shares of HCA Healthcare during the fourth quarter valued at approximately $840,286,000. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Stock Performance

Shares of NYSE HCA traded down $5.20 during trading hours on Friday, hitting $372.84. 943,125 shares of the stock were exchanged, compared to its average volume of 1,461,363. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.19 and a quick ratio of 1.06. The company's 50 day moving average is $370.64 and its 200 day moving average is $338.65. The firm has a market capitalization of $89.69 billion, a P/E ratio of 16.58, a P/E/G ratio of 1.31 and a beta of 1.47. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings data on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.75 by $0.70. The business had revenue of $18.32 billion during the quarter, compared to the consensus estimate of $18.26 billion. HCA Healthcare had a net margin of 8.07% and a return on equity of 1,063.91%. HCA Healthcare's quarterly revenue was up 5.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $5.36 EPS. On average, research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, June 30th. Investors of record on Monday, June 16th were issued a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.77%. The ex-dividend date of this dividend was Monday, June 16th. HCA Healthcare's dividend payout ratio is currently 12.81%.

Insiders Place Their Bets

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the stock in a transaction on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the sale, the chief operating officer directly owned 12,646 shares of the company's stock, valued at $4,670,420.72. This represents a 55.38% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.30% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on HCA shares. Robert W. Baird restated a "neutral" rating and set a $336.00 price target (down previously from $396.00) on shares of HCA Healthcare in a report on Tuesday, April 15th. Royal Bank Of Canada reiterated an "outperform" rating and issued a $404.00 price objective (up previously from $376.00) on shares of HCA Healthcare in a research note on Monday, June 23rd. Wall Street Zen lowered shares of HCA Healthcare from a "buy" rating to a "hold" rating in a research note on Friday, June 27th. Wells Fargo & Company upgraded shares of HCA Healthcare from an "underweight" rating to an "equal weight" rating and upped their price objective for the company from $320.00 to $385.00 in a research note on Thursday, May 29th. Finally, Guggenheim assumed coverage on shares of HCA Healthcare in a research note on Wednesday, April 9th. They issued a "neutral" rating on the stock. Eight equities research analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, HCA Healthcare has a consensus rating of "Moderate Buy" and a consensus price target of $395.71.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.